LifEscozul™ and patient care
Over the past 17 years, we have treated thousands of cancer patients. The results range from improving the quality of life to controlling the disease and thus exceeding the life expectations provided initially.
These results would not have been possible without a personalized treatment and care from the first contact between the patient and ourselves. From our point of view, each patient is unique and the reaction of their body may be different from that of another patient with the same type of cancer. This forces us to look at the patient in a comprehensive way where all the associated factors, not just cancer, must be analyzed.
How do we work with the patient?
At first, we begin to establish an approach with the patient or his relatives. We are interested in knowing the details related to the disease, how the patient and family have assumed it, what is the mood of the patient and what is the support of the family and the doctors in charge of the case.
Most patients come to us in a delicate emotional state for different reasons. Sometimes the disease is recently diagnosed, and it's difficult to process. In other cases, it's because of the stress caused by the changes in daily life related to the disease, its symptoms, and treatments. Some patients have been struggling for a long time, and they get tired and lose hope of finding an effective solution.
This situation does not cover only the patient, family members also go through difficult times to see the suffering of their loved one daily and the uncertainty of knowing if they will be able to get through it. This ends up becoming a vicious circle, in which each feels bad about each other's suffering, and where both sides have complex feelings like guilt and anguish.
Whenever possible, we try to get closer and help them understand the situation which sometimes involves saying things that doctors, for whatever reasons, do not usually say or explain well. This is something we have detected constantly in dealing with patients where in many cases, the patient and his family are not aware of the actual situation of the disease and therefore do not have real expectations about the case.
Patient care should be comprehensive, communicative, differentiated, considering it as a whole
This is not the patient's responsibility. Unfortunately, doctors do not always explain in simple and easy-to-understand words what the patient has and what their situation is. For us, it is common to receive patients who think that they have only the primary tumor, however, when analyzing the documentation, we see the cancer has spread to other organs, which implies a more complicated situation of the disease and the patient and his relatives are not aware of this progress and therefore what to expect.
These situations are handled very tactfully first informing relatives, and then explaining to the patient the real seriousness of the case, if their emotional state allows it. This method of work, where honesty and reality are well received, helps to create the necessary framework of trust to be able to monitor the case closely and strive for the best possible results.
Every patient who enters our work protocols has a tool at their disposal, which we consider essential, which is monitoring.
What is Follow-Up?
When the patient receives Escozul™, part of a dose and concentration as personalized as possible. It is sought, with the customization of the dose, to obtain positive results before the first 90 days. The only way to measure these results is by monitoring the patient, in such a way that a weekly or biweekly report is generated, detailing the effects observed with the use of Escozul™. What will this tell us? Mainly if the dose is being effective and to what extent. On that basis, decision making can be made quickly in case the expected results are not being achieved, ensuring that the effectiveness of Escozul™ is not compromised. Read: How is Escozul™ made?
Every 45 days we request blood tests to observe the evolution of tumor markers, in cases where they are measured, hoping that during that time of treatment their values begin to fall, or at least remain stable.
Every three months, a comparative imaging examination should be performed, to observe the behavior of the disease, and determine whether with the prescribed dose it has managed to slow or stop its progress.
It is important to emphasize that at each of these control moments, our specialists have the opportunity to make changes in treatment to improve the results that are being observed.
However, there is an important detail in the Follow-up, if the patient or their relatives do not contact us at the indicated times, we do not have a way to evaluate the results of the treatment and therefore we cannot know how the indicated dose is working. We cannot pursue patients or violate their privacy; it is the responsibility of the patient or their family member to keep in touch. Our responsibility is to be available at all times and give the corresponding follow-up for each case.
Monitoring is the fundamental basis of the results achieved with Escozul™
Everyone on treatment provides a wealth of information that helps us improve the way we deal with the disease. This brings us a little closer to excellence in treatment and getting better results in less time. These successes allow us to offer a real way to deal with cancer.
You, Escozul™ and us, are part of a comprehensive solution that only works if we work as a whole, in close coordination. That's the goal we've been pursuing from day one.
